id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-E-0092-0005,FDA,FDA-2008-E-0092,Exhibit C [Maintenance Fee Payment],Supporting & Related Material,APP-Application,2008-02-11T05:00:00Z,2008,2,,,2008-04-11T22:38:39Z,,0,0,09000064803aca64
FDA-2008-E-0092-0001,FDA,FDA-2008-E-0092,Sepracor Inc. - Patent Term Extension Application,Other,APP-Application,2008-02-11T05:00:00Z,2008,2,2008-02-11T05:00:00Z,,2008-04-11T22:38:38Z,,0,0,09000064803a9375
FDA-2008-E-0092-0002,FDA,FDA-2008-E-0092,USPTO -  Letter,Other,LET-Letter,2008-02-11T05:00:00Z,2008,2,2008-02-11T05:00:00Z,,2008-04-11T22:38:39Z,,0,0,09000064803a9386
FDA-2008-E-0092-0006,FDA,FDA-2008-E-0092,Exhibit D [Maintenance Fee Payment],Supporting & Related Material,APP-Application,2008-02-11T05:00:00Z,2008,2,,,2008-04-11T22:38:38Z,,0,0,09000064803aca6c
FDA-2008-E-0092-0003,FDA,FDA-2008-E-0092,Exhibit A [UCB Pharma S.A. Authorization Letter],Supporting & Related Material,APP-Application,2008-02-11T05:00:00Z,2008,2,,,2008-04-11T22:38:39Z,,0,0,09000064803aca5e
FDA-2008-E-0092-0007,FDA,FDA-2008-E-0092,Exhibit E [FDA Chronology of Significant Activities],Supporting & Related Material,APP-Application,2008-02-11T05:00:00Z,2008,2,,,2008-04-11T22:38:39Z,,0,0,09000064803aca71
FDA-2008-E-0092-0004,FDA,FDA-2008-E-0092,"Exhibit B [Copy of US Patent No. 5,698,558]",Supporting & Related Material,APP-Application,2008-02-11T05:00:00Z,2008,2,,,2008-04-11T22:38:39Z,,0,0,09000064803aca61